ScholarIQanswers from OpenAlex

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

PaperCitations, authors & open-access status

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma have?

ScholarIQcitation count

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma has 342 citations in the OpenAlex counts ScholarIQ stores.

When was Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma published?

ScholarIQyear

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma has 2008 year in the ScholarIQ index.

What is the open-access status of Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma?

ScholarIQoa status

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma has bronze oa status in the ScholarIQ index.

What is the DOI of Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma?

ScholarIQdoi

The DOI for Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma is on the source record.

What is the PMID of Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma?

ScholarIQpmid

The PMID for Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma is on the source record.

What is the OpenAlex record for Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma?

ScholarIQopenalex

The OpenAlex for Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial